Literature DB >> 1173831

Hypertension. Management in a prepaid health care project.

J P LoGerfo.   

Abstract

Previous studies have shown that care for hypertension in clinical practice is not optimal. This study consists of a review of medical records of 101 hypertensive patients enrolled in a community prepaid health care project, in which all direct costs to patients are eliminated and in which patients are known to have geographical access to care. The results show that even under such conditions, there are deficiencies in what is done in the diagnosis and management of hypertension (process of care). Furthermore, recorded blood pressures in the medical records indicate that 34% of identified patients had diastolic pressures greater than 95 mm Hg at the time of last visit for hypertension.

Entities:  

Mesh:

Year:  1975        PMID: 1173831     DOI: 10.1001/jama.233.3.245

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

1.  Semiautomated reminder system for improving syphilis management.

Authors:  R N Winickoff; K L Coltin; S J Fleishman; G O Barnett
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

2.  Treatment adherence in hypertension: problems and research.

Authors:  W A van Veen
Journal:  J R Coll Gen Pract Occas Pap       Date:  1980-07

3.  The organization of medical practice and primary care physician income.

Authors:  F D Wolinsky; W D Marder
Journal:  Am J Public Health       Date:  1983-04       Impact factor: 9.308

4.  Biofeedback-aided relaxation and meditation in the management of hypertension.

Authors:  C H Patel
Journal:  Biofeedback Self Regul       Date:  1977-03

5.  Nontraditional problems of antihypertensive management.

Authors:  P Rudd; K I Marton
Journal:  West J Med       Date:  1979-09

6.  Limitations of provider interventions in hypertension quality assurance.

Authors:  R N Winickoff; S Wilner; R Neisuler; G O Barnett
Journal:  Am J Public Health       Date:  1985-01       Impact factor: 9.308

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.